Active Share (vs S&P 500): 100.0%
· vs QQQ: 100.0%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
-34.4%
· vs SPY
-36.6%
· Prev Value $170.05M
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
+0.1%
· vs SPY
-2.1%
· Latest Value $110.59M
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, HARBOURVEST PARTNERS LLC disclosed 7 equity positions with a combined reported value of $110.59M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Financials Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were KLAR ($62.24M), GENB ($25.87M), XNDU ($8.89M). By sector, the heaviest allocations are Financials 56.3%, Health Care 28.1%. Versus the prior quarter, allocation shifted toward Health Care (+7.7pp) and away from Financials (-3.5pp), Technology (-4.2pp).
Versus the prior quarter, HARBOURVEST PARTNERS LLC opened 1 new positions, trimmed 1 and fully exited 0, a turnover rate of 28.6% of positions. The portfolio's overlap with the prior quarter was 86% of names.
The largest new positions opened in Q3 2026 were MRLN ($480.25K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest HARBOURVEST PARTNERS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
HARBOURVEST PARTNERS LLC is a global private equity and venture capital firm founded in 1983 by Bruce A. Cohen and Steven A. Davis, headquartered in Boston, MA, focusing on long-term value investing.
Investment Approach
Harbourvest specializes in growth equity, venture capital, and secondary investments, seeking companies with long-term growth potential globally.
Asset Classes
The firm's portfolio spans multiple sectors including technology, healthcare, financial services, consumer, and industrial, with investments ranging from millions to hundreds of millions of dollars.
Global Presence
Harbourvest maintains offices across North America, Europe, and Asia, providing capital and strategic support to companies worldwide.
Key People
Bruce A. Cohen and Steven A. Davis serve as co-founders and jointly lead the firm's investment strategy and operations.
For detailed information about Harbourvest Partners, please refer to their official disclosures and SEC filings.
AI Rebalance Analysis
1. Overall direction and market view: The fund reduced exposure to XNDU (-9.3% shares) while increasing weights on GENB, YMM, and CAMP, suggesting a cautious tilt toward established tech/healthcare names and reduced appetite for speculative quantum tech. No new sectors added.
2. Key moves:
- Reduced: XNDU (shares -9.3%, weight -7.2pp).
- Added: MRLN (new position, 0.43% weight).
- No adds/reductions for other holdings (action=Hold).
3. Portfolio structure: Active management with overweight bias to Financials (KLARNA) and Health Care (GENB, CAMP, IPSC). Moderate risk appetite—avoids extreme bets (e.g., XNDU cut) but retains high-conviction positions (KLAR 56%).
4. Per-holding one-liner:
- KLAR: Financials (BNPL) – *unverified* (PLC suggests Europe-listed).
- GENB: Health Care (AI drug discovery).
- XNDU: Technology (quantum computing).
- YMM: Technology (logistics platform).
- CAMP: Health Care (AI therapeutics).
- MRLN: Technology (unverified).
- IPSC: Health Care (stem cell therapeutics).
5. Style summary: Rotated from speculative quantum (XNDU) to established tech/healthcare, with a new small-cap tech bet (MRLN).
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 13:23
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2024-Q4 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
Why there is no forecast NAV
Not published because:
Holdings-forecast backtest F1 < 0.80 · Top-10 quarterly turnover > 20%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q3)
P 100%R 86%F1 92%(modelled on 2026-Q2; 6/10 hit)
Low-confidence forecast
This fund replaces about 31% of its Top-10 each quarter and
backtests at F1 70% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-16.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.
Portfolio return-1.96%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+15.05%vs benchmark
Barra annualised vol66.3%Model estimate
Realised vol50.7%Annualised in window
Weighted beta1.83Raw exposure
Factor / specific risk41% / 59%Share of variance
Top-10 concentration100.0%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
-1.96%
Disclosed long book
QQQ synthetic benchmark
-17.01%
Liquidity-weighted constituents
Model universe, equal weight
-1.70%
Opportunity-cost reference
Excess return
+15.05%
Portfolio − benchmark
Arithmetic return sum
-0.33%
Difference vs compounded is the cross term
Weighted raw beta
1.83
Weighted holding betas
Realised volatility (annualised)
50.70%
Daily returns in window
Barra model volatility (annualised)
66.27%
Factor + specific
Factor share of variance
40.7%
Barra factors
Specific share of variance
59.3%
Stock residuals
Reported value
$96.0M
13F long US equity
2. Return attribution
The -0.33% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
-8.84%
-2695.6%
Momentum & Growth
3
+3.50%
1067.2%
Volatility & Tail Risk
7
+11.39%
3473.9%
Industry
12
-0.36%
-109.7%
Specific
1
-6.02%
-1835.8%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Kurtosis
Style
+1.70
+7.51%
+12.72%
3880.8%
Skewness
Style
-1.85
-4.39%
+8.13%
2479.6%
Residual Volatility
Style
+1.73
+3.29%
+5.71%
1741.5%
Beta
Style
+1.00
+4.44%
+4.44%
1352.9%
Momentum
Style
-0.98
-4.00%
+3.93%
1199.7%
Size
Style
-1.66
-1.95%
+3.23%
985.8%
Non-linear Size
Style
+3.07
+1.01%
+3.10%
945.2%
Max Drawdown
Style
-1.59
-1.76%
+2.80%
854.7%
Health Care
Industry
+0.27
+6.98%
+1.88%
573.9%
Short-term Reversal
Style
+0.61
+0.87%
+0.53%
162.7%
Liquidity
Style
-0.54
+0.36%
-0.19%
-58.2%
Information Technology
Industry
+0.08
-5.13%
-0.42%
-129.1%
Growth
Style
-0.55
+1.75%
-0.97%
-295.1%
Amihud Illiquidity
Style
+2.75
-0.45%
-1.23%
-374.0%
Financials
Industry
+0.65
-2.80%
-1.82%
-554.5%
Leverage (Downside Vol)
Style
+2.97
-1.71%
-5.09%
-1553.3%
Mid Cap
Style
+2.67
-1.94%
-5.17%
-1577.0%
Specific
Specific
—
—
-6.02%
-1835.8%
Turnover
Style
+1.79
-4.80%
-8.58%
-2617.4%
Historical Volatility
Style
+1.24
-14.00%
-17.32%
-5282.3%
3. Risk attribution
Annualised volatility is 66.27%; factor risk explains 40.7% of variance and specific risk 59.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
59.3%
+39.30%
39.3%
Leverage (Downside Vol)
Style
+2.97
10.1%
+6.66%
6.7%
Historical Volatility
Style
+1.24
7.4%
+4.93%
4.9%
Mid Cap
Style
+2.67
6.7%
+4.45%
4.5%
Financials
Industry
+0.65
6.1%
+4.06%
4.1%
Non-linear Size
Style
+3.07
3.7%
+2.45%
2.5%
Beta
Style
+1.00
2.9%
+1.93%
1.9%
Residual Volatility
Style
+1.73
2.5%
+1.67%
1.7%
Size
Style
-1.66
2.0%
+1.36%
1.4%
Momentum
Style
-0.98
1.2%
+0.79%
0.8%
Health Care
Industry
+0.27
1.1%
+0.71%
0.7%
Max Drawdown
Style
-1.59
1.0%
+0.66%
0.7%
Amihud Illiquidity
Style
+2.75
0.8%
+0.54%
0.5%
Turnover
Style
+1.79
0.7%
+0.48%
0.5%
Information Technology
Industry
+0.08
0.7%
+0.44%
0.4%
Short-term Reversal
Style
+0.61
-0.4%
-0.27%
-0.3%
Kurtosis
Style
+1.70
-2.2%
-1.46%
-1.5%
Skewness
Style
-1.85
-3.7%
-2.47%
-2.5%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
-1.66
+2.10
-3.76
Non-linear Size
+3.07
+1.68
+1.39
Mid Cap
+2.67
+0.13
+2.54
Beta
+1.00
+1.29
-0.30
Momentum
-0.98
+0.72
-1.70
Short-term Reversal
+0.61
-0.64
+1.25
Residual Volatility
+1.73
-0.40
+2.13
Historical Volatility
+1.24
+0.86
+0.38
Liquidity
-0.54
+0.11
-0.65
Amihud Illiquidity
+2.75
+1.16
+1.60
Turnover
+1.79
+0.21
+1.58
Growth
-0.55
+0.58
-1.14
Leverage (Downside Vol)
+2.97
+0.14
+2.83
Skewness
-1.85
+0.24
-2.09
Kurtosis
+1.70
+0.21
+1.48
Max Drawdown
-1.59
-0.08
-1.51
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
8.2%
73.6%
+3.51%
-22.33%
+3.40%
+19.02%
-16.89%
+16.73%
Financials
64.8%
0.0%
+10.01%
+0.00%
+11.10%
+0.00%
+6.49%
+6.49%
Communication Services
0.0%
2.6%
+0.00%
-17.64%
+0.01%
+0.46%
-0.46%
+0.46%
Utilities
0.0%
0.8%
+0.00%
+11.13%
-0.22%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.26%
-0.27%
-0.13%
+0.13%
-0.13%
Consumer Discretionary
0.0%
8.8%
+0.00%
+3.76%
-1.84%
-0.33%
+0.33%
-0.33%
Industrials
0.0%
11.1%
+0.00%
+4.36%
-2.39%
-0.48%
+0.48%
-0.48%
Health Care
26.9%
1.7%
-30.16%
+8.29%
+6.41%
-0.66%
-9.69%
-8.27%
Total
+16.09%
+17.76%
-19.50%
+14.35%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
KLAR
KLARNA GROUP PLC
Financials
64.81%
+10.01%
+6.49%
Hold
GENB
GENERATE BIOMEDICINES INC
Health Care
26.94%
-30.16%
-8.12%
Hold
YMM
FULL TRUCK ALLIANCE CO LTD
Information Technology
8.25%
+3.51%
+0.29%
Hold
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
KLAR
Financials
64.81%
+10.01%
+6.49%
2
YMM
Information Technology
8.25%
+3.51%
+0.29%
3
GENB
Health Care
26.94%
-30.16%
-8.12%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -1.96%, versus -17.01% for the QQQ synthetic benchmark — an excess of +15.05%.
Return attribution: the largest positive style/industry contributions came from Kurtosis +12.72%, Skewness +8.13%, Residual Volatility +5.71%; the largest drags came from Historical Volatility -17.32%, Turnover -8.58%, Mid Cap -5.17%. Specific (stock-level) return contributed -6.02%.
Risk attribution: Barra model volatility is 66.27% annualised; factor risk explains 41% of variance and specific risk 59%. The largest factor risk sources are Leverage (Downside Vol) 10.1%, Historical Volatility 7.4%, Mid Cap 6.7%.
Style tilt: size -1.66, momentum -0.98, volatility +1.24, liquidity -0.54; the weighted raw beta is 1.83. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Financials (+64.8 pp), the largest underweight is Information Technology (-65.4 pp). Allocation contributed +16.09%, selection +17.76% and interaction -19.50%.
Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did HARBOURVEST PARTNERS LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, HARBOURVEST PARTNERS LLC reported 7 equity positions worth $110.59M in aggregate; its largest disclosed positions were KLAR ($62.24M), GENB ($25.87M), XNDU ($8.89M).
How large is HARBOURVEST PARTNERS LLC's portfolio?
HARBOURVEST PARTNERS LLC reported $110.59M of long equity holdings across 7 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.
What is HARBOURVEST PARTNERS LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Financials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/harbourvest-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>